The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
Open accessAbstract
Chronic HBV (CHB) infection suppresses virus-specific T cells, but its impact on humoral immunity has been poorly analyzed. Here, we developed a dual-staining method that utilizes hepatitis B virus (HBV) surface antigens (HBsAg) labeled with fluorochromes as "baits" for specific ex vivo detection of HBsAg-specific B cells and analysis of their quantity, function, and phenotype. We studied healthy vaccinated subjects (n = 18) and patients with resolved (n = 21), acute (n = 11), or chronic (n = 96) HBV infection and observed that frequencies of circulating HBsAg-specific B cells were independent of HBV infection status. In contrast, the presence of serum HBsAg affected function and phenotype of HBsAg-specific B cells that were unable to mature in vitro into Ab-secreting cells and displayed an increased expression of markers linked to hyperactivation (CD21lo) and exhaustion (PD-1). Importantly, B cell alterations were not limited to HBsAg-specific B cells, but affected the global B cell population. HBsAg-specific B cell maturation could be partially restored by a method involving the combination of the cytokines IL-2 and IL-21 and CD40L-expressing feeder cells and was further boosted by the addition of anti-PD-1 Abs. In conclusion, HBV infection has a marked impact on global and HBV-specific humoral immunity, yet HBsAg-specific B cells are amenable to a partial rescue by B cell-maturing cytokines and PD-1 blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Dimensionality reduction for visualizing single-cell data using UMAP
Becht, E., McInnes, L., Healy, J., Dutertre, C.-A., Kwok, I. W. H., Ng, L. G., Ginhoux, F., & Newell, E. W. (2019) · Nature Biotechnology · doi:10.1038/nbt.4314 · Cited by 5,358
Self-citationMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Self-citationMoir, S., Ho, J., Malaspina, A., Wang, W., DiPoto, A. C., O'Shea, M. A., Roby, G., Kottilil, S., Arthos, J., Proschan, M. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072683 · Cited by 901
Maini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1269 · Cited by 800
Self-citationEnhancing SIV-specific immunity in vivo by PD-1 blockade
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., et al. (2009) · Nature · doi:10.1038/nature07662 · Cited by 771
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
Self-citationWebster, G. J. M., Reignat, S., Brown, D., Ogg, G. S., Jones, L., Seneviratne, S. L., Williams, R., Dusheiko, G., & Bertoletti, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5707-5719.2004 · Cited by 387
Self-citationMaini, M. K., Boni, C., Ogg, G. S., King, A. S., Reignat, S., Lee, C. K., Larrubia, J. R., Webster, G. J. M., McMichael, A. J., Ferrari, C., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70289-1 · Cited by 366
Self-citationPD-1 is a novel regulator of human B-cell activation
Thibult, M.-L., Mamessier, E., Gertner-Dardenne, J., Pastor, S., Just-Landi, S., Xerri, L., Chetaille, B., & Olive, D. (2013) · International Immunology · doi:10.1093/intimm/dxs098 · Cited by 365 · cited 1×
“PD-1 is a negative regulator of T cell activation, but it is also expressed by B cells and can regulate human B cell maturation (43).”
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Urban, S., Bartenschlager, R., Kubitz, R., & Zoulim, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.030 · Cited by 361
Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 341
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Burton, A. R., Pallett, L. J., McCoy, L. E., Suveizdyte, K., Amin, O. E., Swadling, L., Alberts, E., Davidson, B. R., Kennedy, P. T. F., Gill, U. S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121960 · Cited by 330
Self-citationPortugal, S., Tipton, C. M., Sohn, H., Kone, Y., Wang, J., Li, S., Skinner, J., Virtaneva, K., Sturdevant, D. E., Porcella, S. F., et al. (2015) · eLife · doi:10.7554/elife.07218 · Cited by 329
Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
Kennedy, P. T. F., Sandalova, E., Jo, J., Gill, U., Ushiro–Lumb, I., Tan, A. T., Naik, S., Foster, G. R., & Bertoletti, A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.009 · Cited by 307
Self-citationHepatitis B virus morphogenesis
Bruss, V. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.65 · Cited by 289
Bengsch, B., Martin, B., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.005 · Cited by 284
Gish, R. G., Given, B. D., Lai, C.-L., Locarnini, S. A., Lau, J. Y. N., Lewis, D. L., & Schluep, T. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.008 · Cited by 259
Schurich, A., Pallett, L. J., Jajbhay, D., Wijngaarden, J., Otano, I., Gill, U. S., Hansi, N., Kennedy, P. T., Nastouli, E., Gilson, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.078 · Cited by 256
Self-citationJourdan, M., Caraux, A., De Vos, J., Fiol, G., Larroque, M., Cognot, C., Bret, C., Duperray, C., Hose, D., & Klein, B. (2009) · Blood · doi:10.1182/blood-2009-07-235960 · Cited by 247
Barnaba, V., Franco, A., Alberti, A., Benvenuto, R., & Balsano, F. (1990) · Nature · doi:10.1038/345258a0 · Cited by 206
Isolation of human monoclonal antibodies from peripheral blood B cells
Huang, J., Doria-Rose, N. A., Longo, N. S., Laub, L., Lin, C.-L., Turk, E., Kang, B. H., Migueles, S. A., Bailer, R. T., Mascola, J. R., et al. (2013) · Nature Protocols · doi:10.1038/nprot.2013.117 · Cited by 168
Kardava, L., Moir, S. L., Wang, W., Ho, J., Buckner, C. M., Posada, J. G., O’Shea, M. A., Roby, G. A., Chen, J., Sohn, H. W., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45685 · Cited by 166
Oliviero, B., Cerino, A., Varchetta, S., Paudice, E., Pai, S. S., Ludovisi, S., Zaramella, M., Michelone, G., Pugnale, P., Negro, F., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.016 · Cited by 163
Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells
Obeng-Adjei, N., Portugal, S., Holla, P., Li, S., Sohn, H., Ambegaonkar, A., Skinner, J., Bowyer, G., Doumbo, O. K., Traore, B., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006576 · Cited by 163
Oxenius, A., Zinkernagel, R. M., & Hengartner, H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80628-7 · Cited by 162
Paul, S., Dickstein, A. M., Saxena, A., Terrin, N., Viveiros, K., Balk, E., & Wong, J. B. (2017) · Hepatology · doi:10.1002/hep.29082 · Cited by 154
FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure
Sullivan, R. T., Kim, C. C., Fontana, M. F., Feeney, M. E., Jagannathan, P., Boyle, M. J., DRAKELEY, C. J., Ssewanyana, I., Nankya, F., Mayanja‐Kizza, H., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004894 · Cited by 152
Jahnmatz, M., Kesa, G., Netterlid, E., Buisman, A., Thorstensson, R., & Ahlborg, N. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.02.009 · Cited by 150
Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals
Kardava, L., Moir, S. L., Shah, N., Wang, W., Wilson, R., Buckner, C. M., Santich, B. H., Kim, L. J. Y., Spurlin, E. E., Nelson, A. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74351 · Cited by 149
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
Na, Z., Yeo, S. P., Bharath, S. R., Bowler, M. W., Balıkçı, E., Wang, C., & Song, H. (2016) · Cell Research · doi:10.1038/cr.2016.77 · Cited by 149
Zhang, T., Yuan, Q., Zhao, J.-H., Zhang, Y., Yuan, L., Lan, Y., Lo, Y.-C., Sun, C., Wu, C., Zhang, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308964 · Cited by 137
Xu, X., Shang, Q., Chen, X., Nie, W., Zou, Z., Huang, A., Meng, M., Jin, L., Xu, R., Zhang, J., et al. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.25 · Cited by 118
Kurktschiev, P., Raziorrouh, B., Schraut, W., Backmund, M., Wächtler, M., Wendtner, C., Bengsch, B., Thimme, R., Denk, G., Zachoval, R., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131333 · Cited by 115
Vanwolleghem, T., Hou, J., van Oord, G., Andeweg, A. C., Osterhaus, A. D. M. E., Pas, S. D., Janssen, H. L. A., & Boonstra, A. (2015) · Hepatology · doi:10.1002/hep.27805 · Cited by 110
Wang, X., Dong, Q., Li, Q., Li, Y., Zhao, D., Sun, J., Fu, J., Meng, F., Lin, H., Luan, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.021 · Cited by 105
Yu, M., Li, G., Lee, W.-W., Yuan, M., Cui, D., Weyand, C. M., & Goronzy, J. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109797109 · Cited by 102
Current treatments for chronic hepatitis B virus infections
Zoulim, F., Lebossé, F., & Levrero, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.06.004 · Cited by 96
Li, Y., Ma, S., Tang, L., Li, Y., Wang, W., Huang, X., Lai, Q., Zhang, M., Sun, J., Li, C. K.-F., et al. (2013) · Hepatology · doi:10.1002/hep.26489 · Cited by 95
T-bet-expressing B cells during HIV and HCV infections
Knox, J. J., Kaplan, D. E., & Betts, M. R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.04.012 · Cited by 60
CD83 Modulates B Cell Function In Vitro: Increased IL-10 and Reduced Ig Secretion by CD83Tg B Cells
Kretschmer, B., Lüthje, K., Guse, A. H., Ehrlich, S., Koch‐Nolte, F., Haag, F., Fleischer, B., & Breloer, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000755 · Cited by 50
Single epitope multiple staining to detect ultralow frequency B cells
Townsend, S. E., Goodnow, C. C., & Cornall, R. J. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00352-5 · Cited by 43
An OX40/OX40L interaction directs successful immunity to hepatitis B virus
Publicover, J., Gaggar, A., Jespersen, J. M., Halac, U., Johnson, A. J., Goodsell, A., Avanesyan, L., Nishimura, S. L., Holdorf, M. M., Mansfield, K. G., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5766 · Cited by 43
Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans
Tian, C., Chen, Y., Liu, Y., Wang, S., Li, Y., Wang, G., Xia, J., Zhao, X., Huang, R., Lu, S., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0034-0 · Cited by 42
Lee, J., Park, J. Y., Huh, K. H., Kim, B. S., Kim, M. S., Kim, S. I., Ahn, S. H., & Kim, Y. S. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw455 · Cited by 41
Ward, S. M., Phalora, P. K., Bradshaw, D., Leyendeckers, H., & Klenerman, P. (2008) · The Journal of Infectious Diseases · doi:10.1086/591094 · Cited by 35
Viral subversion of B cell responses within secondary lymphoid organs
Kuka, M., & Iannacone, M. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.133 · Cited by 35
Hanihara-Tatsuzawa, F., Takahashi, Y., Okuma, A., Ohba, T., & Muta, T. (2013) · International Immunology · doi:10.1093/intimm/dxt017 · Cited by 18
Cited by
Therapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Self-citationImmunobiology and pathogenesis of hepatitis B virus infection
Iannacone, M., & Guidotti, L. G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00549-4 · Cited by 520
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Burton, A. R., Pallett, L. J., McCoy, L. E., Suveizdyte, K., Amin, O. E., Swadling, L., Alberts, E., Davidson, B. R., Kennedy, P. T. F., Gill, U. S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121960 · Cited by 330
Self-citationLiver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
HBV-Induced Immune Imbalance in the Development of HCC
Chen, Y., & Tian, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02048 · Cited by 270
Metadata
- Authors
- Salimzadeh, L., Le Bert, N., Dutertre, C.-A., Gill, U. S., Newell, E. W., Frey, C., Hung, M., Novikov, N., Fletcher, S., Kennedy, P. T. F., & Bertoletti, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-08-07
- Volume
- 128
- Issue
- 10
- Pages
- 4573-4587
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2885273410
- Cited by
- 290
- References
- 50
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.